Data is not available at this time.
Perrot Duval Holding S.A. operates in the industrial machinery sector, specializing in automation technologies for process automation. The company develops and sells original components and solutions tailored for industries such as chemicals, pharmaceuticals, food, and cosmetics. Its core offerings include automated dispensing and safety systems, which streamline manufacturing processes for paints, inks, dyes, and other specialty products. Perrot Duval serves a global clientele, positioning itself as a niche provider of precision automation solutions. The company’s market position is reinforced by its focus on high-value, customized systems that enhance efficiency in complex production environments. While it operates in a competitive industrial automation space, its specialization in dispensing technologies for chemical and pharmaceutical applications provides a defensible niche. However, its small scale relative to multinational competitors may limit its ability to compete on price or broad technological integration.
In FY 2024, Perrot Duval reported revenue of CHF 18.2 million but recorded a net loss of CHF 286,000, reflecting margin pressures or operational inefficiencies. The diluted EPS of -2.13 CHF underscores these challenges. Operating cash flow was positive at CHF 630,000, though capital expenditures of CHF 791,000 suggest ongoing investments, possibly in R&D or capacity upgrades.
The company’s negative net income indicates weak earnings power, though its modest debt (CHF 426,000) and cash reserves (CHF 3.2 million) provide some financial flexibility. The positive operating cash flow suggests core operations are generating liquidity, but profitability remains a concern given the net loss.
Perrot Duval maintains a conservative balance sheet with CHF 3.2 million in cash and limited total debt (CHF 426,000). This low leverage supports financial stability, though the net loss and negative EPS highlight operational challenges. The company’s ability to sustain dividends (CHF 1 per share) despite losses may indicate confidence in future cash flows or a commitment to shareholder returns.
Revenue trends are unclear without prior-year comparisons, but the net loss suggests stagnant or declining profitability. The dividend payout of CHF 1 per share is notable given the negative earnings, potentially signaling a prioritization of shareholder returns over reinvestment. Future growth may hinge on expanding its automation solutions in niche chemical and pharmaceutical markets.
With a market cap of CHF 7.8 million and a beta of 0.14, the stock is thinly traded and exhibits low volatility. The negative earnings and modest revenue base likely limit investor enthusiasm, though the dividend yield could attract income-focused shareholders. The valuation reflects skepticism about near-term turnaround prospects.
Perrot Duval’s specialization in dispensing systems for chemicals and pharmaceuticals provides a competitive edge in niche markets. However, its small scale and recent losses pose risks. The outlook depends on its ability to improve margins, expand its customer base, or innovate in high-value automation segments. A focus on operational efficiency and targeted R&D could help stabilize profitability.
Company description, financial data from public filings (likely Swiss Exchange disclosures), and market data from financial platforms.
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |